R&D News | pharmaphorum

News

Big UK trial says hydroxychloroquine has no effect on COVID-...

The largest trial to date on hydroxychloroquine has concluded it has “no beneficial effect” when used to treat patients hospitalised with COVID-19.

News

Alnylam's shares dip as analyst backs rival after rare disea...

Alnylam has revealed the data that forms the basis of its filings for its latest potential rare disease drug lumasiran, but shares dipped after an analyst suggested it could be outperformed

News

Coronavirus vaccine: how pharma is picking up the pace

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

President Donald Trump’s Operation Warp Speed, which aims to make a coronavirus vaccine widely available by year-end, has come up with a shortlist of candidates, with some nota

News

AZ makes plans to supply 2 billion doses of COVID-19 vaccine

AstraZeneca has announced new plans to increase the global supply of Oxford University’s COVID-19 vaccine to more than two billion doses after striking agreements with several global not-fo

News